Direkt zum Inhalt
Merck
  • Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus.

Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus.

Cell reports. Medicine (2024-07-18)
Francesca Bertino, Dibyanti Mukherjee, Massimo Bonora, Christoph Bagowski, Jeannette Nardelli, Livia Metani, Diletta Isabella Zanin Venturini, Diego Chianese, Nicolas Santander, Iris Chiara Salaroglio, Andreas Hentschel, Elisa Quarta, Tullio Genova, Arpana Arjun McKinney, Anna Lucia Allocco, Veronica Fiorito, Sara Petrillo, Giorgia Ammirata, Francesco De Giorgio, Evan Dennis, Garrett Allington, Felicitas Maier, Moneef Shoukier, Karl-Philipp Gloning, Luca Munaron, Federico Mussano, Ettore Salsano, Davide Pareyson, Maja di Rocco, Fiorella Altruda, Georgia Panagiotakos, Kristopher T Kahle, Pierre Gressens, Chiara Riganti, Paolo P Pinton, Andreas Roos, Thomas Arnold, Emanuela Tolosano, Deborah Chiabrando
ZUSAMMENFASSUNG

Congenital hydrocephalus (CH), occurring in approximately 1/1,000 live births, represents an important clinical challenge due to the limited knowledge of underlying molecular mechanisms. The discovery of novel CH genes is thus essential to shed light on the intricate processes responsible for ventricular dilatation in CH. Here, we identify FLVCR1 (feline leukemia virus subgroup C receptor 1) as a gene responsible for a severe form of CH in humans and mice. Mechanistically, our data reveal that the full-length isoform encoded by the FLVCR1 gene, FLVCR1a, interacts with the IP3R3-VDAC complex located on mitochondria-associated membranes (MAMs) that controls mitochondrial calcium handling. Loss of Flvcr1a in mouse neural progenitor cells (NPCs) affects mitochondrial calcium levels and energy metabolism, leading to defective cortical neurogenesis and brain ventricle enlargement. These data point to defective NPCs calcium handling and metabolic activity as one of the pathogenetic mechanisms driving CH.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Roche
cOmplete, Mini, EDTA-freier Protease-Inhibitor-Cocktail, Tablets provided in EASYpacks
Sigma-Aldrich
Phosphatasehemmer-Cocktail 3, DMSO solution
Roche
cOmplete Proteasehemmer-Cocktail, Tablets provided in EASYpacks
Sigma-Aldrich
Histamin -dihydrochlorid, ≥99% (TLC), powder
Sigma-Aldrich
Ethylendiamintetraessigsäure, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
Carbamoylcholinchlorid, ≥98% (titration), crystalline
Sigma-Aldrich
Phenylmethylsulfonylfluorid, Phenylmethylsulfonyl Fluoride, CAS 329-98-6, is an irreversible inhibitor of serine proteases. It causes sulfonylation of the active-site serine residues.
Millipore
Protease-Inhibitor-Cocktail-Set III, frei von tierischen Bestandteilen, Protease Inhibitor Cocktail Set III, Animal-Free, is a cocktail of six protease inhibitors with broad specificity for the inhibition of aspartic, cysteine & serine proteases & aminopeptidases.
Sigma-Aldrich
Anti-Vinculin antibody, Mouse monoclonal, clone V284, purified from hybridoma cell culture
Sigma-Aldrich
Anti-SIGMAR1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution